Kevin L. Best

413 total citations
10 papers, 324 citations indexed

About

Kevin L. Best is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Kevin L. Best has authored 10 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in Kevin L. Best's work include Hormonal and reproductive studies (4 papers), Prostate Cancer Treatment and Research (4 papers) and Estrogen and related hormone effects (3 papers). Kevin L. Best is often cited by papers focused on Hormonal and reproductive studies (4 papers), Prostate Cancer Treatment and Research (4 papers) and Estrogen and related hormone effects (3 papers). Kevin L. Best collaborates with scholars based in United States. Kevin L. Best's co-authors include David T. Wong, Penny G. Threlkeld, F.P. Bymaster, Robin L. Goode, Blake Lee Neubauer, Lee R. Tanzer, Ronald L. Merriman, D. M. Hoover, R. Tamura and Carl J. Shaar and has published in prestigious journals such as The Journal of Urology, Journal of Pharmacology and Experimental Therapeutics and Toxicology and Applied Pharmacology.

In The Last Decade

Kevin L. Best

10 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin L. Best United States 9 85 72 68 64 58 10 324
Beate Lubrich Germany 10 55 0.6× 159 2.2× 96 1.4× 22 0.3× 84 1.4× 12 508
Eric Arehart United States 12 67 0.8× 171 2.4× 51 0.8× 33 0.5× 26 0.4× 14 393
Bernadette Hughes United Kingdom 10 95 1.1× 137 1.9× 42 0.6× 20 0.3× 27 0.5× 14 345
P. Schlesinger Australia 11 60 0.7× 157 2.2× 44 0.6× 12 0.2× 100 1.7× 14 550
Adelheid Wiemer‐Kruel Germany 12 50 0.6× 85 1.2× 194 2.9× 30 0.5× 26 0.4× 23 518
Ruth Seemann United States 12 172 2.0× 185 2.6× 181 2.7× 43 0.7× 9 0.2× 13 511
Katsuhiko Hamaguchi Japan 11 69 0.8× 104 1.4× 27 0.4× 56 0.9× 15 0.3× 39 380
Qinghe Xing China 9 62 0.7× 151 2.1× 102 1.5× 10 0.2× 17 0.3× 17 343
Mark Gardiner United Kingdom 11 142 1.7× 203 2.8× 99 1.5× 11 0.2× 15 0.3× 18 528
Purnima P. Desai United States 8 73 0.9× 126 1.8× 27 0.4× 6 0.1× 51 0.9× 8 349

Countries citing papers authored by Kevin L. Best

Since Specialization
Citations

This map shows the geographic impact of Kevin L. Best's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin L. Best with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin L. Best more than expected).

Fields of papers citing papers by Kevin L. Best

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin L. Best. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin L. Best. The network helps show where Kevin L. Best may publish in the future.

Co-authorship network of co-authors of Kevin L. Best

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin L. Best. A scholar is included among the top collaborators of Kevin L. Best based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin L. Best. Kevin L. Best is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Neubauer, Blake Lee, Kevin L. Best, David F. Counts, et al.. (1995). Raloxifene (LY156758) produces antimetastatic responses and extends survival in the paiii rat prostatic adenocarcinoma model. The Prostate. 27(4). 220–229. 24 indexed citations
2.
Neubauer, Blake Lee, Kevin L. Best, Thomas R. Blohm, et al.. (1993). LY207320 (6‐methylene‐4‐pregnene‐3,20‐dione) inhibits testosterone biosynthesis, androgen uptake, 5α‐reductase, and produces prostatic regression in male rats. The Prostate. 23(3). 181–199. 8 indexed citations
3.
Neubauer, Blake Lee, Kevin L. Best, James A. Clemens, et al.. (1993). Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat. The Prostate. 23(3). 245–262. 24 indexed citations
4.
Neubauer, Blake Lee, Ronald L. Merriman, Kevin L. Best, et al.. (1992). Inhibition of PAIII Rat Prostatic Adenocarcinoma Growth and Metastasis by a New Diarylsulfonylurea Antitumor Agent, LY181984. The Journal of Urology. 147(2). 500–504. 5 indexed citations
5.
Neubauer, Blake Lee, Robin L. Goode, Kevin L. Best, et al.. (1990). Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat. Toxicology and Applied Pharmacology. 102(2). 219–232. 9 indexed citations
6.
Hoover, D. M., et al.. (1990). Experimental induction of neoplasia in the accessory sex organs of male Lobund-Wistar rats.. PubMed. 50(1). 142–6. 40 indexed citations
7.
Smith, Gerald F., Blake Lee Neubauer, Kevin L. Best, et al.. (1988). Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat. Thrombosis Research. 50(1). 163–174. 28 indexed citations
8.
Neubauer, Blake Lee, Kerry G. Bemis, Kevin L. Best, et al.. (1986). Inhibitory Effect of Warfarin on the Metastasis of the PAIII Prostatic Adenocarcinoma in the Rat. The Journal of Urology. 135(1). 163–166. 16 indexed citations
9.
Neubauer, Blake Lee, Kerry G. Bemis, Kevin L. Best, et al.. (1986). Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the rat. The Prostate. 8(3). 265–276. 10 indexed citations
10.
Wong, David T., Penny G. Threlkeld, Kevin L. Best, & F.P. Bymaster. (1982). A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.. Journal of Pharmacology and Experimental Therapeutics. 222(1). 61–65. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026